/
Health Resources and Services Administration, U.S. Department of Health and Human Services
Enrollment Period
Open enrollment
The 340B Drug Pricing Program requires pharmaceutical manufacturers participating in Medicaid to sell outpatient drugs at significantly reduced prices to eligible health care organizations (covered entities), which in turn use the savings to expand services or reduce costs for low-income and uninsured patients. Covered entities include FQHCs, Ryan White clinics, disproportionate-share hospitals, and other safety-net providers. Patients receiving care at 340B-covered entities — particularly the uninsured — often benefit from deeply discounted prescription drugs.
Answer each question — we'll show you exactly what applies to your situation.
Do you receive care at a 340B-covered entity?
Uninsured patients and those meeting the entity's sliding-fee criteria benefit most from 340B pricing
Individual patients do not enroll in 340B directly — access is through covered health care providers
Coverage entities set their own policies for passing on drug discounts to patients